News

BEAMER’s Innovative Research on AI-Driven Treatment Adherence Prediction Recognised at International Conference

BEAMER’s Innovative Research on AI-Driven Treatment Adherence Prediction Recognised at International Conference
A conference highlight was the acceptance of BEAMER’s study titled ‘Multi-stakeholder Approach for Designing an AI Model to Predict Treatment Adherence’.

In a remarkable showcase of cutting-edge research and innovation, Beatriz Merino from BEAMER’s Work Package 2 participated in the 25th International Conference on Human-Computer Interaction, hosted at the prestigious AC Bella Sky Hotel and Bella Center.

The conference served as a global platform for sharing advancements in the realm of human-computer interaction. Beatriz represented BEAMER and presented groundbreaking work accomplished within the project.

Her presentation revolved around the outcomes of Work Package 2, a pivotal phase involving the execution of a comprehensive stakeholder strategy. This expertly designed approach aimed to gather essential model requirements, playing a crucial role in shaping the direction of BEAMER’s research. The presentation delved into the intricacies of stakeholder engagement and highlighted results obtained through this collaborative approach.

A conference highlight was the acceptance of BEAMER’s study titled ‘Multi-stakeholder Approach for Designing an AI Model to Predict Treatment Adherence’.

This remarkable achievement underscores BEAMER’s commitment to developing innovative solutions that bridge the gap between technology and healthcare. In this study, semi-structured interviews were conducted with eleven stakeholders from four groups: patients, healthcare professionals, data scientists, and pharmacists. The needs and requirements received were categorised into four key aspects that were translated into requirements and needs: understanding the nature of the drivers, scope, and impact of the problem; identifying data sources; understanding relevant data points; and addressing potential ethical issues.

“We are thrilled to have our work recognized at such a prestigious international forum,” said Beatriz. “This acknowledgement is a testament to the hard work of the entire BEAMER team and the collaborative spirit of our stakeholders.”

Explore the study’s publication here, offering readers an in-depth exploration of the innovative approach and its potential impact on treatment adherence prediction.

NEWS​

Related News

Evondos Anna in Siun Sote, Finland: Technology brings quality home care to sparsely-populated areas

9 Apr 2024
In Siun Sote, it is believed that medicine-dispensing robots will increasingly establish themselves as part of future home care. In North Karelia, dem...

ECHAlliance Announces Reciprocal Agreement with AgeTech Atlanta

8 Apr 2024
ECHAlliance and AgeTech Atlanta forge a Foundation Partnership to drive AgeTech Innovation and Excellence

Digital Health Collaboration: ECHAlliance Session at Africa-Europe Science Forum

8 Apr 2024
Connecting the Dots: ECHAlliance Hosts session on Digital Health Collaboration at Africa-Europe Science Collaboration and Innovation Forum

New Foundations 2024

8 Apr 2024
New Foundations is a key driver in progressing our strategic priorities by enabling awardees to pursue research, networking or dissemination activitie...

Neurotech Entrepreneurship to Validate Emerging Innovations (NERVE)

8 Apr 2024
The NERVE (Neurotech Entrepreneurship to Validate Emerging Innovations) program is Canada's single largest award that catalyzes early stage entreprene...

Horizon Europe Pump Priming Programme

8 Apr 2024
The programme supports individual UK SMEs wanting to explore and access Horizon Europe collaborative research and innovation opportunities.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *